Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(33%)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Terminated(1)
Other(1)

Detailed Status

Active, not recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

active_not_recruiting133%
terminated133%
unknown133%

Recent Activity

1 active trials
Showing 3 of 3
unknownnot_applicable

JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study

NCT02732691
active_not_recruitingnot_applicable

THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

NCT02732704
terminatednot_applicable

First in Man Study of the JenaValve TAVI Plus System Transfemoral

NCT02818959

Clinical Trials (3)

Showing 3 of 3 trials
NCT02732691Not Applicable

JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study

Unknown
NCT02732704Not Applicable

THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

Active Not Recruiting
NCT02818959Not Applicable

First in Man Study of the JenaValve TAVI Plus System Transfemoral

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3